- Home
- WSFS vs XENE Comparison
WSFS vs XENE Comparison
Compare WSFS & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WSFS | XENE |
|---|---|---|
| Founded | 1980 | 1996 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 3.7B |
| IPO Year | 1995 | 2014 |
Fundamental Metrics
Financial Performance| Metric | WSFS | XENE |
|---|---|---|
| Price | $78.98 | $36.00 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 19 |
| Target Price | ★ $88.92 | $71.94 |
| AVG Volume (30 Days) | 264.5K | ★ 1.5M |
| Earning Date | 10-22-2026 | 11-06-2026 |
| Dividend Yield | ★ 1.00% | N/A |
| EPS Growth | ★ 15.42 | N/A |
| EPS | ★ 3.26 | N/A |
| Revenue | ★ $963,949,000.00 | $311,000.00 |
| Revenue This Year | $7.25 | N/A |
| Revenue Next Year | $5.20 | $2,045.70 |
| P/E Ratio | $24.33 | ★ N/A |
| Revenue Growth | ★ 50.18 | N/A |
| 52 Week Low | $50.91 | $33.38 |
| 52 Week High | $82.94 | $72.66 |
Technical Indicators
Market Signals| Indicator | WSFS | XENE |
|---|---|---|
| Relative Strength Index (RSI) | 60.37 | 36.02 |
| Support Level | $76.71 | $33.38 |
| Resistance Level | $81.87 | $43.68 |
| Average True Range (ATR) | 1.35 | 1.15 |
| MACD | 0.50 | 0.90 |
| Stochastic Oscillator | 79.28 | 68.51 |
Price Performance
Historical ComparisonAbout WSFS WSFS Financial Corporation
WSFS Financial Corp is a savings and loan holding company. The company operates in three segments: the WSFS Bank segment provides loans and leases, and other financial products to commercial and consumer customers; the Cash Connect segment provides ATM vault cash, smart safe, and other cash logistics services; and the Wealth and Trust segment provides a broad array of planning and advisory services, investment management, trust services, and credit and deposit products to individual, corporate, and institutional clients. The majority of revenue is generated from the WSFS Bank segment.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.